APO Research
Talk to an analyst

APO RESEARCH · REPORT

Disease Control and Prevention Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Disease Control and Prevention Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchDisease Control and Prevention Vaccine Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Disease Control and Prevention Vaccine Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Disease Control and Prevention Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Disease Control and Prevention Vaccine Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Disease Control and Prevention Vaccine Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Disease Control and Prevention Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Disease Control and Prevention Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Disease Control and Prevention Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Disease Control and Prevention Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Disease Control and Prevention Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Disease Control and Prevention Vaccine include GSK, Takeda Pharmaceutical Company Limited, Sanofi, Johnson & Johnson, Pfizer, Daiichi Sankyo, AstraZeneca PLC, Sinovac Biotech Ltd and Serum Institute of India Pvt. Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Disease Control and Prevention Vaccine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Disease Control and Prevention Vaccine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Disease Control and Prevention Vaccine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Disease Control and Prevention Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Disease Control and Prevention Vaccine Segment by Company

GSK

Takeda Pharmaceutical Company Limited

Sanofi

Johnson & Johnson

Pfizer

Daiichi Sankyo

AstraZeneca PLC

Sinovac Biotech Ltd

Serum Institute of India Pvt. Ltd

Panacea Biotec Ltd

Novavax Inc

Mitsubishi Tanabe Pharma Corporation

Merck & Co., Inc

Inovio Pharmaceuticals Inc

Emergent BioSolutions Inc

CSL Limited

Bharat Biotech International

Bavarian Nordic A/S

Astellas Pharma Inc

Abbott Laboratories

Disease Control and Prevention Vaccine Segment by Type

Live-Attenuated

Inactivated

Recombinant Sub Unit and Toxoid

Disease Control and Prevention Vaccine Segment by Application

Pediatric Vaccine

Adult Vaccine

Disease Control and Prevention Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Disease Control and Prevention Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Disease Control and Prevention Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Disease Control and Prevention Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Disease Control and Prevention Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Disease Control and Prevention Vaccine industry.

Chapter 3: Detailed analysis of Disease Control and Prevention Vaccine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Disease Control and Prevention Vaccinerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Live-Attenuated Table 3. Key Players of Inactivated Table 4. Key Players of Recombinant Sub Unit and Toxoid Table 4. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pediatric Vaccine Table 6. Key Players of Adult Vaccine Table 7. Global Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Disease Control and Prevention Vaccine Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Disease Control and Prevention Vaccine Market Share by Region (2021-2026) Table 10. Global Disease Control and Prevention Vaccine Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Disease Control and Prevention Vaccine Market Share by Region (2027-2032) Table 12. Disease Control and Prevention Vaccine Industry Trends Table 13. Disease Control and Prevention Vaccine Industry Drivers Table 14. Disease Control and Prevention Vaccine Industry Opportunities and Challenges Table 15. Disease Control and Prevention Vaccine Industry Restraints Table 16. Global Disease Control and Prevention Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Disease Control and Prevention Vaccine Revenue Market Share by Company (2021-2026) Table 18. Global Disease Control and Prevention Vaccine Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Disease Control and Prevention Vaccine Key Company Head Office and Area Served Table 20. Global Disease Control and Prevention Vaccine Company, Product Type & Application Table 21. Global Disease Control and Prevention Vaccine Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Disease Control and Prevention Vaccine Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Disease Control and Prevention Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Disease Control and Prevention Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2021-2026) Table 28. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2027-2032) Table 29. Global Disease Control and Prevention Vaccine Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Disease Control and Prevention Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Disease Control and Prevention Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2021-2026) Table 33. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2027-2032) Table 34. GSK Company Information Table 35. GSK Business Overview Table 36. GSK Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. GSK Disease Control and Prevention Vaccine Product Portfolio Table 38. GSK Recent Development Table 39. Takeda Pharmaceutical Company Limited Company Information Table 40. Takeda Pharmaceutical Company Limited Business Overview Table 41. Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Product Portfolio Table 43. Takeda Pharmaceutical Company Limited Recent Development Table 44. Sanofi Company Information Table 45. Sanofi Business Overview Table 46. Sanofi Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Sanofi Disease Control and Prevention Vaccine Product Portfolio Table 48. Sanofi Recent Development Table 49. Johnson & Johnson Company Information Table 50. Johnson & Johnson Business Overview Table 51. Johnson & Johnson Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Johnson & Johnson Disease Control and Prevention Vaccine Product Portfolio Table 53. Johnson & Johnson Recent Development Table 54. Pfizer Company Information Table 55. Pfizer Business Overview Table 56. Pfizer Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Pfizer Disease Control and Prevention Vaccine Product Portfolio Table 58. Pfizer Recent Development Table 59. Daiichi Sankyo Company Information Table 60. Daiichi Sankyo Business Overview Table 61. Daiichi Sankyo Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolio Table 63. Daiichi Sankyo Recent Development Table 64. AstraZeneca PLC Company Information Table 65. AstraZeneca PLC Business Overview Table 66. AstraZeneca PLC Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolio Table 68. AstraZeneca PLC Recent Development Table 69. Sinovac Biotech Ltd Company Information Table 70. Sinovac Biotech Ltd Business Overview Table 71. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolio Table 73. Sinovac Biotech Ltd Recent Development Table 74. Serum Institute of India Pvt. Ltd Company Information Table 75. Serum Institute of India Pvt. Ltd Business Overview Table 76. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolio Table 78. Serum Institute of India Pvt. Ltd Recent Development Table 79. Panacea Biotec Ltd Company Information Table 80. Panacea Biotec Ltd Business Overview Table 81. Panacea Biotec Ltd Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Panacea Biotec Ltd Disease Control and Prevention Vaccine Product Portfolio Table 83. Panacea Biotec Ltd Recent Development Table 84. Novavax Inc Company Information Table 85. Novavax Inc Business Overview Table 86. Novavax Inc Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Novavax Inc Disease Control and Prevention Vaccine Product Portfolio Table 88. Novavax Inc Recent Development Table 89. Mitsubishi Tanabe Pharma Corporation Company Information Table 90. Mitsubishi Tanabe Pharma Corporation Business Overview Table 91. Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Product Portfolio Table 93. Mitsubishi Tanabe Pharma Corporation Recent Development Table 94. Merck & Co., Inc Company Information Table 95. Merck & Co., Inc Business Overview Table 96. Merck & Co., Inc Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolio Table 98. Merck & Co., Inc Recent Development Table 99. Inovio Pharmaceuticals Inc Company Information Table 100. Inovio Pharmaceuticals Inc Business Overview Table 101. Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Product Portfolio Table 103. Inovio Pharmaceuticals Inc Recent Development Table 104. Emergent BioSolutions Inc Company Information Table 105. Emergent BioSolutions Inc Business Overview Table 106. Emergent BioSolutions Inc Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Emergent BioSolutions Inc Disease Control and Prevention Vaccine Product Portfolio Table 108. Emergent BioSolutions Inc Recent Development Table 109. CSL Limited Company Information Table 110. CSL Limited Business Overview Table 111. CSL Limited Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. CSL Limited Disease Control and Prevention Vaccine Product Portfolio Table 113. CSL Limited Recent Development Table 114. Bharat Biotech International Company Information Table 115. Bharat Biotech International Business Overview Table 116. Bharat Biotech International Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Bharat Biotech International Disease Control and Prevention Vaccine Product Portfolio Table 118. Bharat Biotech International Recent Development Table 119. Bavarian Nordic A/S Company Information Table 120. Bavarian Nordic A/S Business Overview Table 121. Bavarian Nordic A/S Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Bavarian Nordic A/S Disease Control and Prevention Vaccine Product Portfolio Table 123. Bavarian Nordic A/S Recent Development Table 124. Astellas Pharma Inc Company Information Table 125. Astellas Pharma Inc Business Overview Table 126. Astellas Pharma Inc Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 127. Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolio Table 128. Astellas Pharma Inc Recent Development Table 129. Abbott Laboratories Company Information Table 130. Abbott Laboratories Business Overview Table 131. Abbott Laboratories Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 132. Abbott Laboratories Disease Control and Prevention Vaccine Product Portfolio Table 133. Abbott Laboratories Recent Development Table 134. North America Disease Control and Prevention Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 135. North America Disease Control and Prevention Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 136. North America Disease Control and Prevention Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 137. North America Disease Control and Prevention Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 138. North America Disease Control and Prevention Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. North America Disease Control and Prevention Vaccine Market Size by Country (2021-2026) Table 140. North America Disease Control and Prevention Vaccine Market Size by Country (2027-2032) Table 141. Europe Disease Control and Prevention Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 142. Europe Disease Control and Prevention Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 143. Europe Disease Control and Prevention Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 144. Europe Disease Control and Prevention Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 145. Europe Disease Control and Prevention Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Europe Disease Control and Prevention Vaccine Market Size by Country (2021-2026) Table 147. Europe Disease Control and Prevention Vaccine Market Size by Country (2027-2032) Table 148. China Disease Control and Prevention Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 149. China Disease Control and Prevention Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 150. China Disease Control and Prevention Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 151. China Disease Control and Prevention Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 152. Asia Disease Control and Prevention Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 153. Asia Disease Control and Prevention Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 154. Asia Disease Control and Prevention Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 155. Asia Disease Control and Prevention Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 156. Asia Disease Control and Prevention Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia Disease Control and Prevention Vaccine Market Size by Country (2021-2026) Table 158. Asia Disease Control and Prevention Vaccine Market Size by Country (2027-2032) Table 159. South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 160. South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 161. South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 162. South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 163. South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2021-2026) Table 165. South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2027-2032) Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Disease Control and Prevention Vaccine Product Image Figure 2. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Disease Control and Prevention Vaccine Market Share by Type: 2025 VS 2032 Figure 4. Live-Attenuated Image Figure 5. Inactivated Image Figure 6. Recombinant Sub Unit and Toxoid Image Figure 7. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Disease Control and Prevention Vaccine Market Share by Application: 2025 VS 2032 Figure 9. Pediatric Vaccine Image Figure 10. Adult Vaccine Image Figure 11. Global Disease Control and Prevention Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 13. Global Disease Control and Prevention Vaccine Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Disease Control and Prevention Vaccine Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Disease Control and Prevention Vaccine Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Disease Control and Prevention Vaccine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2021-2032) Figure 20. Global Disease Control and Prevention Vaccine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2021-2032) Figure 22. North America Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 23. North America Disease Control and Prevention Vaccine Market Share by Type (2021-2032) Figure 24. North America Disease Control and Prevention Vaccine Market Share by Application (2021-2032) Figure 25. North America Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 26. United States Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 27. Canada Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 29. Europe Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 30. Europe Disease Control and Prevention Vaccine Market Share by Type (2021-2032) Figure 31. Europe Disease Control and Prevention Vaccine Market Share by Application (2021-2032) Figure 32. Europe Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 33. Germany Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 34. France Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 36. Italy Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 37. Russia Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 39. China Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 40. China Disease Control and Prevention Vaccine Market Share by Type (2021-2032) Figure 41. China Disease Control and Prevention Vaccine Market Share by Application (2021-2032) Figure 42. Asia Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 43. Asia Disease Control and Prevention Vaccine Market Share by Type (2021-2032) Figure 44. Asia Disease Control and Prevention Vaccine Market Share by Application (2021-2032) Figure 45. Asia Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 46. Japan Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 50. India Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 51. Australia Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Disease Control and Prevention Vaccine Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Disease Control and Prevention Vaccine Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 56. Brazil Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 61. UAE Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 63. Chile Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Live-Attenuated
  • Inactivated
  • Recombinant Sub Unit and Toxoid
Applications
  • Pediatric Vaccine
  • Adult Vaccine
Companies covered
  • GSK
  • Takeda Pharmaceutical Company Limited
  • Sanofi
  • Johnson & Johnson
  • Pfizer
  • Daiichi Sankyo
  • AstraZeneca PLC
  • Sinovac Biotech Ltd
  • Serum Institute of India Pvt. Ltd
  • Panacea Biotec Ltd
  • Novavax Inc
  • Mitsubishi Tanabe Pharma Corporation
  • Merck & Co., Inc
  • Inovio Pharmaceuticals Inc
  • Emergent BioSolutions Inc
  • CSL Limited
  • Bharat Biotech International
  • Bavarian Nordic A/S
  • Astellas Pharma Inc
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Live-Attenuated
  5. 1.2.3 Inactivated
  6. 1.2.4 Recombinant Sub Unit and Toxoid
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Pediatric Vaccine
  10. 1.3.3 Adult Vaccine
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Disease Control and Prevention Vaccine Growth Trends by Region
  13. 1.5.1 Global Disease Control and Prevention Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Disease Control and Prevention Vaccine Market Size by Region (2021-2026)
  15. 1.5.3 Disease Control and Prevention Vaccine Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Disease Control and Prevention Vaccine Market Dynamics
  1. 2.1 Disease Control and Prevention Vaccine Industry Trends
  2. 2.2 Disease Control and Prevention Vaccine Industry Drivers
  3. 2.3 Disease Control and Prevention Vaccine Industry Opportunities and Challenges
  4. 2.4 Disease Control and Prevention Vaccine Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Disease Control and Prevention Vaccine Revenue by Company (2021-2026)
  2. 3.2 Global Disease Control and Prevention Vaccine Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Disease Control and Prevention Vaccine Key Company Head office and Area Served
  4. 3.4 Global Disease Control and Prevention Vaccine Company, Product Type & Application
  5. 3.5 Global Disease Control and Prevention Vaccine Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Disease Control and Prevention Vaccine Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Disease Control and Prevention Vaccine Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Disease Control and Prevention Vaccine Tier 1, Tier 2, and Tier 3
4 Disease Control and Prevention Vaccine Market by Type
  1. 4.1 Global Disease Control and Prevention Vaccine Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Disease Control and Prevention Vaccine Market Size by Type (2021-2032)
  3. 4.3 Global Disease Control and Prevention Vaccine Market Size Share by Type (2021-2032)
5 Disease Control and Prevention Vaccine Market by Application
  1. 5.1 Global Disease Control and Prevention Vaccine Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Disease Control and Prevention Vaccine Market Size by Application (2021-2032)
  3. 5.3 Global Disease Control and Prevention Vaccine Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 GSK Disease Control and Prevention Vaccine Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Takeda Pharmaceutical Company Limited
  8. 6.2.1 Takeda Pharmaceutical Company Limited Company Information
  9. 6.2.2 Takeda Pharmaceutical Company Limited Business Overview
  10. 6.2.3 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Product Portfolio
  12. 6.2.5 Takeda Pharmaceutical Company Limited Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sanofi Disease Control and Prevention Vaccine Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Johnson & Johnson Disease Control and Prevention Vaccine Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pfizer Disease Control and Prevention Vaccine Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Daiichi Sankyo
  32. 6.6.1 Daiichi Sankyo Company Information
  33. 6.6.2 Daiichi Sankyo Business Overview
  34. 6.6.3 Daiichi Sankyo Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolio
  36. 6.6.5 Daiichi Sankyo Recent Developments
  37. 6.7 AstraZeneca PLC
  38. 6.7.1 AstraZeneca PLC Company Information
  39. 6.7.2 AstraZeneca PLC Business Overview
  40. 6.7.3 AstraZeneca PLC Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolio
  42. 6.7.5 AstraZeneca PLC Recent Developments
  43. 6.8 Sinovac Biotech Ltd
  44. 6.8.1 Sinovac Biotech Ltd Company Information
  45. 6.8.2 Sinovac Biotech Ltd Business Overview
  46. 6.8.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolio
  48. 6.8.5 Sinovac Biotech Ltd Recent Developments
  49. 6.9 Serum Institute of India Pvt. Ltd
  50. 6.9.1 Serum Institute of India Pvt. Ltd Company Information
  51. 6.9.2 Serum Institute of India Pvt. Ltd Business Overview
  52. 6.9.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolio
  54. 6.9.5 Serum Institute of India Pvt. Ltd Recent Developments
  55. 6.10 Panacea Biotec Ltd
  56. 6.10.1 Panacea Biotec Ltd Company Information
  57. 6.10.2 Panacea Biotec Ltd Business Overview
  58. 6.10.3 Panacea Biotec Ltd Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Panacea Biotec Ltd Disease Control and Prevention Vaccine Product Portfolio
  60. 6.10.5 Panacea Biotec Ltd Recent Developments
  61. 6.11 Novavax Inc
  62. 6.11.1 Novavax Inc Company Information
  63. 6.11.2 Novavax Inc Business Overview
  64. 6.11.3 Novavax Inc Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Novavax Inc Disease Control and Prevention Vaccine Product Portfolio
  66. 6.11.5 Novavax Inc Recent Developments
  67. 6.12 Mitsubishi Tanabe Pharma Corporation
  68. 6.12.1 Mitsubishi Tanabe Pharma Corporation Company Information
  69. 6.12.2 Mitsubishi Tanabe Pharma Corporation Business Overview
  70. 6.12.3 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Product Portfolio
  72. 6.12.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
  73. 6.13 Merck & Co., Inc
  74. 6.13.1 Merck & Co., Inc Company Information
  75. 6.13.2 Merck & Co., Inc Business Overview
  76. 6.13.3 Merck & Co., Inc Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolio
  78. 6.13.5 Merck & Co., Inc Recent Developments
  79. 6.14 Inovio Pharmaceuticals Inc
  80. 6.14.1 Inovio Pharmaceuticals Inc Company Information
  81. 6.14.2 Inovio Pharmaceuticals Inc Business Overview
  82. 6.14.3 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Product Portfolio
  84. 6.14.5 Inovio Pharmaceuticals Inc Recent Developments
  85. 6.15 Emergent BioSolutions Inc
  86. 6.15.1 Emergent BioSolutions Inc Company Information
  87. 6.15.2 Emergent BioSolutions Inc Business Overview
  88. 6.15.3 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Product Portfolio
  90. 6.15.5 Emergent BioSolutions Inc Recent Developments
  91. 6.16 CSL Limited
  92. 6.16.1 CSL Limited Company Information
  93. 6.16.2 CSL Limited Business Overview
  94. 6.16.3 CSL Limited Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 CSL Limited Disease Control and Prevention Vaccine Product Portfolio
  96. 6.16.5 CSL Limited Recent Developments
  97. 6.17 Bharat Biotech International
  98. 6.17.1 Bharat Biotech International Company Information
  99. 6.17.2 Bharat Biotech International Business Overview
  100. 6.17.3 Bharat Biotech International Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Bharat Biotech International Disease Control and Prevention Vaccine Product Portfolio
  102. 6.17.5 Bharat Biotech International Recent Developments
  103. 6.18 Bavarian Nordic A/S
  104. 6.18.1 Bavarian Nordic A/S Company Information
  105. 6.18.2 Bavarian Nordic A/S Business Overview
  106. 6.18.3 Bavarian Nordic A/S Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Bavarian Nordic A/S Disease Control and Prevention Vaccine Product Portfolio
  108. 6.18.5 Bavarian Nordic A/S Recent Developments
  109. 6.19 Astellas Pharma Inc
  110. 6.19.1 Astellas Pharma Inc Company Information
  111. 6.19.2 Astellas Pharma Inc Business Overview
  112. 6.19.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolio
  114. 6.19.5 Astellas Pharma Inc Recent Developments
  115. 6.20 Abbott Laboratories
  116. 6.20.1 Abbott Laboratories Company Information
  117. 6.20.2 Abbott Laboratories Business Overview
  118. 6.20.3 Abbott Laboratories Disease Control and Prevention Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Abbott Laboratories Disease Control and Prevention Vaccine Product Portfolio
  120. 6.20.5 Abbott Laboratories Recent Developments
7 North America
  1. 7.1 North America Disease Control and Prevention Vaccine Market Size (2021-2032)
  2. 7.2 North America Disease Control and Prevention Vaccine Market Size by Type
  3. 7.2.1 North America Disease Control and Prevention Vaccine Market Size by Type (2021-2026)
  4. 7.2.2 North America Disease Control and Prevention Vaccine Market Size by Type (2027-2032)
  5. 7.2.3 North America Disease Control and Prevention Vaccine Market Share by Type (2021-2032)
  6. 7.3 North America Disease Control and Prevention Vaccine Market Size by Application
  7. 7.3.1 North America Disease Control and Prevention Vaccine Market Size by Application (2021-2026)
  8. 7.3.2 North America Disease Control and Prevention Vaccine Market Size by Application (2027-2032)
  9. 7.3.3 North America Disease Control and Prevention Vaccine Market Share by Application (2021-2032)
  10. 7.4 North America Disease Control and Prevention Vaccine Market Size by Country
  11. 7.4.1 North America Disease Control and Prevention Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  13. 7.4.3 North America Disease Control and Prevention Vaccine Market Size by Country (2027-2032)
  14. 7.4.4 North America Disease Control and Prevention Vaccine Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Disease Control and Prevention Vaccine Market Size (2021-2032)
  2. 8.2 Europe Disease Control and Prevention Vaccine Market Size by Type
  3. 8.2.1 Europe Disease Control and Prevention Vaccine Market Size by Type (2021-2026)
  4. 8.2.2 Europe Disease Control and Prevention Vaccine Market Size by Type (2027-2032)
  5. 8.2.3 Europe Disease Control and Prevention Vaccine Market Share by Type (2021-2032)
  6. 8.3 Europe Disease Control and Prevention Vaccine Market Size by Application
  7. 8.3.1 Europe Disease Control and Prevention Vaccine Market Size by Application (2021-2026)
  8. 8.3.2 Europe Disease Control and Prevention Vaccine Market Size by Application (2027-2032)
  9. 8.3.3 Europe Disease Control and Prevention Vaccine Market Share by Application (2021-2032)
  10. 8.4 Europe Disease Control and Prevention Vaccine Market Size by Country
  11. 8.4.1 Europe Disease Control and Prevention Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  13. 8.4.3 Europe Disease Control and Prevention Vaccine Market Size by Country (2027-2032)
  14. 8.4.4 Europe Disease Control and Prevention Vaccine Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Disease Control and Prevention Vaccine Market Size (2021-2032)
  2. 9.2 China Disease Control and Prevention Vaccine Market Size by Type
  3. 9.2.1 China Disease Control and Prevention Vaccine Market Size by Type (2021-2026)
  4. 9.2.2 China Disease Control and Prevention Vaccine Market Size by Type (2027-2032)
  5. 9.2.3 China Disease Control and Prevention Vaccine Market Share by Type (2021-2032)
  6. 9.3 China Disease Control and Prevention Vaccine Market Size by Application
  7. 9.3.1 China Disease Control and Prevention Vaccine Market Size by Application (2021-2026)
  8. 9.3.2 China Disease Control and Prevention Vaccine Market Size by Application (2027-2032)
  9. 9.3.3 China Disease Control and Prevention Vaccine Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Disease Control and Prevention Vaccine Market Size (2021-2032)
  2. 10.2 Asia Disease Control and Prevention Vaccine Market Size by Type
  3. 10.2.1 Asia Disease Control and Prevention Vaccine Market Size by Type (2021-2026)
  4. 10.2.2 Asia Disease Control and Prevention Vaccine Market Size by Type (2027-2032)
  5. 10.2.3 Asia Disease Control and Prevention Vaccine Market Share by Type (2021-2032)
  6. 10.3 Asia Disease Control and Prevention Vaccine Market Size by Application
  7. 10.3.1 Asia Disease Control and Prevention Vaccine Market Size by Application (2021-2026)
  8. 10.3.2 Asia Disease Control and Prevention Vaccine Market Size by Application (2027-2032)
  9. 10.3.3 Asia Disease Control and Prevention Vaccine Market Share by Application (2021-2032)
  10. 10.4 Asia Disease Control and Prevention Vaccine Market Size by Country
  11. 10.4.1 Asia Disease Control and Prevention Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  13. 10.4.3 Asia Disease Control and Prevention Vaccine Market Size by Country (2027-2032)
  14. 10.4.4 Asia Disease Control and Prevention Vaccine Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Disease Control and Prevention Vaccine Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst